{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T13:10:13Z","timestamp":1717852213081},"reference-count":33,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/mco.2015.546","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T07:11:06Z","timestamp":1429168266000},"page":"747-752","source":"Crossref","is-referenced-by-count":1,"title":["Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large B-cell lymphoma"],"prefix":"10.3892","volume":"3","author":[{"given":"MAN FAI","family":"LAW","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAY NUN","family":"CHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HO KEI","family":"LAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUNG YIN","family":"HA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CELIA","family":"NG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YIU MING","family":"YEUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SZE FAI","family":"YIP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"key20180107145104_b1-mco-0-0-546","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107145104_b2-mco-0-0-546","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107145104_b3-mco-0-0-546","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann Oncol"},{"key":"key20180107145104_b4-mco-0-0-546","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2008-10-182253","article-title":"CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)","volume":"113","author":"Boehme","year":"2009","journal-title":"Blood"},{"key":"key20180107145104_b5-mco-0-0-546","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516-the southwest oncology group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107145104_b6-mco-0-0-546","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.hoc.2005.05.003","article-title":"Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma","volume":"19","author":"Bierman","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107145104_b7-mco-0-0-546","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry vs. cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"key20180107145104_b8-mco-0-0-546","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180107145104_b9-mco-0-0-546","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"key20180107145104_b10-mco-0-0-546","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"MabThera International Trial Group: CHOP-like chemotherapy plus rituximab vs. CHOP-like chemotherapy alone in young patients with good prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"key":"key20180107145104_b11-mco-0-0-546","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL): Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomized controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180107145104_b12-mco-0-0-546","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL): Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"key":"key20180107145104_b13-mco-0-0-546","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12185-009-0289-2","article-title":"Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience","volume":"89","author":"Shimazu","year":"2009","journal-title":"Int J Hematol"},{"key":"key20180107145104_b14-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/annonc\/mdp432","article-title":"Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy","volume":"21","author":"Villa","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107145104_b15-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1470-2045(11)70140-1","article-title":"Prevention of CNS relapse in diffuse large B-cell lymphoma","volume":"12","author":"Kridel","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107145104_b16-mco-0-0-546","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-005-1096-3","article-title":"Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system","volume":"85","author":"Jahnke","year":"2006","journal-title":"Ann Hematol"},{"key":"key20180107145104_b17-mco-0-0-546","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1349-7006.2011.02139.x","article-title":"Central nervous system event in patients with diffuse large B-cell lymphoma in rituximab era","volume":"103","author":"Tomita","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180107145104_b18-mco-0-0-546","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"key":"key20180107145104_b19-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2007-07-101402","article-title":"Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an international primary CNS lymphoma collaborative group report","volume":"111","author":"Doolittle","year":"2008","journal-title":"Blood"},{"key":"key20180107145104_b20-mco-0-0-546","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00277-010-1104-0","article-title":"Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma","volume":"90","author":"Kim","year":"2011","journal-title":"Ann Hematol"},{"key":"key20180107145104_b21-mco-0-0-546","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1200\/JCO.2006.06.6910","article-title":"Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma","volume":"24","author":"Gavrilovic","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107145104_b22-mco-0-0-546","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3324\/haematol.2012.070839","article-title":"Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an international primary central nervous system lymphoma study group project","volume":"98","author":"Bromberg","year":"2013","journal-title":"Haematologica"},{"key":"key20180107145104_b23-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1080\/1042819021000006475","article-title":"Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma","volume":"43","author":"Chua","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"key20180107145104_b24-mco-0-0-546","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/annonc\/mdl434","article-title":"The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma","volume":"18","author":"Arkenau","year":"2007","journal-title":"Ann Oncol"},{"key":"key20180107145104_b25-mco-0-0-546","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00277-010-1150-7","article-title":"Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab","volume":"90","author":"Tai","year":"2011","journal-title":"Ann Hematol"},{"key":"key20180107145104_b26-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/annonc\/mdr440","article-title":"CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera international trial and trials of the German high-grade non-Hodgkin lymphoma study group","volume":"23","author":"Schmitz","year":"2012","journal-title":"Ann Oncol"},{"key":"key20180107145104_b27-mco-0-0-546","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N Engl J Med"},{"key":"key20180107145104_b28-mco-0-0-546","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","article-title":"Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities","volume":"88","author":"Kwong","year":"2009","journal-title":"Ann Hematol"},{"key":"key20180107145104_b29-mco-0-0-546","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for CNS involvement: the role of flow cytometry vs. cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"key20180107145104_b30-mco-0-0-546","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1002\/cncr.25278","article-title":"Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma","volume":"116","author":"Abramson","year":"2010","journal-title":"Cancer"},{"key":"key20180107145104_b31-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/bjc.2014.405","article-title":"A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma","volume":"111","author":"Cheah","year":"2014","journal-title":"Br J Cancer"},{"key":"key20180107145104_b32-mco-0-0-546","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/annonc\/mds621","article-title":"Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell\/follicular grade 3 lymphoma patients: results of a phase II Nordic lymphoma group study","volume":"24","author":"Holte","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180107145104_b33-mco-0-0-546","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2010.01438.x","article-title":"Central nervous system involvement in diffuse large B-cell lymphoma","volume":"85","author":"Yamamoto","year":"2010","journal-title":"Eur J Haematol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2015.546\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T12:23:01Z","timestamp":1717849381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2015.546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,16]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/mco.2015.546"],"URL":"https:\/\/doi.org\/10.3892\/mco.2015.546","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}